ARCHIVE

• Press Seminar
  September 8, 2003

• New Waves in the Generic Drug Industry (1)
  September 8, 2003

• NEW PRODUCTS
  September 8, 2003

• Financial Results in 1st Quarter
  September 8, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  September 8, 2003

• Korosho Budget Request for 2004 Totals \20 Trillion
  September 8, 2003

• OTC NEWS IN BRIEF
  September 8, 2003

• Korosho Calls For Attention to ADRs due to Tamiflu, Diovan
  September 8, 2003

• Korosho to Revise Priority NDA Review System
  September 8, 2003

• Reductions in NHI Prices, Medical Fees Inevitable in 2004
  September 8, 2003

• REGULATORY NEWS IN BRIEF
  September 8, 2003

• GE Use at National Hospitals Increasing Steadily: Survey
  September 8, 2003

• EpiPen Is Milestone for the Future: Mr Diehl of Merck Ltd.
  September 8, 2003

• Meet the Leaders (24)
  September 8, 2003

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  September 8, 2003

• Sales of Generic Pravastatin, Simvastatin Sluggish So Far: Survey
  September 8, 2003

• JCR Licenses MSC Technology from Osiris Therapeutics of US
  September 8, 2003

• Sankyo to Begin Implementing RDRD Project This Year
  September 8, 2003

• Sosei Balances R&D Risk with 7 Compounds in Pipeline
  September 8, 2003

• AstraZeneca to Build Marketing System in CNS Field via Zomig
  September 8, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 577
• 578
• 579
• 580
• 581
• 582
• 583
• 584
• 585
• …
• Next ›
• 最終 »